Crackdown on Illegal Ayurvedic Syrup Factory: An Inside Look

In Madhya Pradesh’s Indore district, officials sealed an illegal Ayurvedic syrup factory located in a residential area. The factory, overseen by Surendra Singh, was found lacking a quality-test lab and proper documentation. It was shut down for multiple regulatory infractions including hygiene and safety violations.

Authorities sealed an illegal Ayurvedic syrup factory in Indore district, Madhya Pradesh, on Thursday. The factory, located in a residential area in Dharampuri village, produced over 30 types of syrups.

The operation was led by Surendra Singh, who failed to provide essential documentation for the ingredients used in the syrup production. Furthermore, the facility lacked a laboratory for quality testing, raising significant safety and hygiene concerns.

The factory was shut down for violating pharmaceutical manufacturing regulations, and an investigation into the matter is ongoing, officials confirmed.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg